Clinical Trial Update: Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ [Phase 2]

View source ↗

Summary

Phase 2 study assessing immunogenicity and safety of a combined Measles-Mumps-Rubella-Varicella vaccine (MeMuRu-OKA) compared with Priorix (MMR) given with Vari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• MeMuRu-OKA
• Priorix (Measles-Mumps-Rubella Vaccine)
• Varilrix (varicella vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Mumps, Rubella | Phase 2 | Status: COMPLETED